| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 23:09:27 UTC |
|---|
| Updated at | 2022-09-07 23:09:27 UTC |
|---|
| NP-MRD ID | NP0257891 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 5β-dihydrotestosterone |
|---|
| Description | 5B-Dihydrotestosterone, also known as 5-beta-DHT or 5-Β-DHT, belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. Thus, 5b-dihydrotestosterone is considered to be a steroid lipid molecule. 5B-Dihydrotestosterone is a drug. 5B-Dihydrotestosterone is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 5B-dihydrotestosterone can be converted into testosterone; which is catalyzed by the enzyme 3-oxo-5-beta-steroid 4-dehydrogenase. 5β-dihydrotestosterone is found in Mus musculus. 5β-dihydrotestosterone was first documented in 1977 (PMID: 591837). In humans, 5b-dihydrotestosterone is involved in androgen and estrogen metabolism (PMID: 10357254) (PMID: 11430920) (PMID: 15758151) (PMID: 17804019) (PMID: 18276759) (PMID: 19215525). |
|---|
| Structure | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14+,15+,16+,17+,18+,19+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (5beta,17beta)-17-Hydroxyandrostan-3-one | ChEBI | | (5beta,8alpha,17beta)-17-Hydroxyandrostan-3-one | ChEBI | | 17beta-Hydroxyetiocholan-3-one | ChEBI | | 5-beta-DHT | ChEBI | | 5beta,17beta-Hydroxyandrostan-3-one | ChEBI | | 5beta-Androstan-17beta-ol-3-one | ChEBI | | Etiocholan-17-beta-ol-3-one | ChEBI | | (5b,17b)-17-Hydroxyandrostan-3-one | Generator | | (5Β,17β)-17-hydroxyandrostan-3-one | Generator | | (5b,8a,17b)-17-Hydroxyandrostan-3-one | Generator | | (5Β,8α,17β)-17-hydroxyandrostan-3-one | Generator | | 17b-Hydroxyetiocholan-3-one | Generator | | 17Β-hydroxyetiocholan-3-one | Generator | | 5-b-DHT | Generator | | 5-Β-DHT | Generator | | 5b,17b-Hydroxyandrostan-3-one | Generator | | 5Β,17β-hydroxyandrostan-3-one | Generator | | 5b-Androstan-17b-ol-3-one | Generator | | 5Β-androstan-17β-ol-3-one | Generator | | Etiocholan-17-b-ol-3-one | Generator | | Etiocholan-17-β-ol-3-one | Generator | | 5beta-Dihydrotestosterone | HMDB | | 17beta-Hydroxy-5beta-androstan-3-one | HMDB |
|
|---|
| Chemical Formula | C19H30O2 |
|---|
| Average Mass | 290.4403 Da |
|---|
| Monoisotopic Mass | 290.22458 Da |
|---|
| IUPAC Name | (1S,2S,7R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-one |
|---|
| Traditional Name | 5β-dihydrotestosterone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C |
|---|
| InChI Identifier | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14+,15+,16+,17+,18+,19+/m1/s1 |
|---|
| InChI Key | NVKAWKQGWWIWPM-MISPCMORSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Androstane steroids |
|---|
| Direct Parent | Androgens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Androgen-skeleton
- 3-oxosteroid
- 3-oxo-5-beta-steroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Cyclic alcohol
- Cyclic ketone
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Organooxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Alcohol
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Perusquia M, Villalon CM: Possible role of Ca2+ channels in the vasodilating effect of 5beta-dihydrotestosterone in rat aorta. Eur J Pharmacol. 1999 Apr 29;371(2-3):169-78. doi: 10.1016/s0014-2999(99)00161-2. [PubMed:10357254 ]
- Bordallo C, Rubin JM, Varona AB, Cantabrana B, Hidalgo A, Sanchez M: Increases in ornithine decarboxylase activity in the positive inotropism induced by androgens in isolated left atrium of the rat. Eur J Pharmacol. 2001 Jun 22;422(1-3):101-7. doi: 10.1016/s0014-2999(01)01039-1. [PubMed:11430920 ]
- Perusquia M, Navarrete E, Jasso-Kamel J, Montano LM: Androgens induce relaxation of contractile activity in pregnant human myometrium at term: a nongenomic action on L-type calcium channels. Biol Reprod. 2005 Aug;73(2):214-21. doi: 10.1095/biolreprod.104.036954. Epub 2005 Mar 9. [PubMed:15758151 ]
- Perusquia M, Navarrete E, Gonzalez L, Villalon CM: The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sci. 2007 Sep 1;81(12):993-1002. doi: 10.1016/j.lfs.2007.07.024. Epub 2007 Aug 7. [PubMed:17804019 ]
- Montano LM, Calixto E, Figueroa A, Flores-Soto E, Carbajal V, Perusquia M: Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade. Endocrinology. 2008 May;149(5):2517-26. doi: 10.1210/en.2007-1288. Epub 2008 Feb 14. [PubMed:18276759 ]
- Schumacher M, Hutchison RE, Hutchison JB: Inhibition of hypothalamic aromatase activity by 5 Beta-dihydrotestosterone. J Neuroendocrinol. 1991 Apr 1;3(2):221-6. doi: 10.1111/j.1365-2826.1991.tb00266.x. [PubMed:19215525 ]
- Massa R, Cresti L, Martini L: Metabolism of testosterone in the anterior pituitary gland and the central nervous system of the European starling (Sturnus vulgaris). J Endocrinol. 1977 Dec;75(3):347-54. doi: 10.1677/joe.0.0750347. [PubMed:591837 ]
- LOTUS database [Link]
|
|---|